SEARCH RESULTS FOR: "Tag: RYTM"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(1)
CATEGORIES
Analyst Update(1)

7/8/2019 12:43 PM
The shares of Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) are getting a boost today, after Canaccord Genuity initiated coverage on the drugmaker with a "buy" rating and a $35 price target -- a more than...
PEOPLE ALSO SEARCH FOR
Partner Center